文献速递精神分裂症与精神病性障碍

精神分裂症精神病性症状患者海马亚区转录组分析

Hippocampal subfield transcriptome analysis in schizophrenia psychosis.
PubMed 文献 · Mol Psychiatry · 2020-03-09

该研究对精神分裂症精神病性症状患者与对照的海马亚区DG、CA3和CA1进行RNA-seq分析,发现亚区特异性分子谱:DG涉及星形胶质细胞、CA3涉及免疫机制、CA1涉及突触缩放。抗精神病药物治疗引起独特亚区特异性基因表达模式,与疾病效应基因重叠很少,可解释常规抗精神病药物对症状疗效不完整。

要点

  • 精神分裂症患者海马DG、CA3、CA1存在亚区特异性分子谱改变。
  • DG涉及星形胶质细胞,CA3涉及免疫机制,CA1涉及突触缩放。
  • 抗精神病药物基因表达效应与疾病效应基因重叠很少。

核心结论

  • 精神分裂症精神病性症状患者海马亚区存在独特分子谱,可解释常规抗精神病药物疗效不完整。

研究设计与样本

  • 对精神分裂症精神病性症状患者与对照的海马亚区DG、CA3和CA1进行RNA-seq分析。
  • 同时分析精神分裂症患者服药与停药队列海马亚区基因表达变化。

主要发现

  • 精神分裂症死后样本海马亚区呈现亚区特异性分子谱:DG涉及星形胶质细胞,CA3涉及免疫机制,CA1涉及突触缩放。
  • 抗精神病药物对基因表达水平呈现独特亚区特异性效应模式。
  • 疾病效应与药物效应差异表达基因重叠很少。

临床怎么用

  • 海马亚区分子改变提示常规抗精神病药物对精神分裂症症状疗效不完整。
  • DG、CA3、CA1的独特分子谱可能为未来海马靶向治疗提供潜在靶点。

局限性

  • 研究为死后组织转录组分析,需未来单细胞研究进一步表征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We have previously demonstrated functional and molecular changes in hippocampal subfields in individuals with schizophrenia (SZ) psychosis associated with hippocampal excitability. In this study, we use RNA-seq and assess global transcriptome changes in the hippocampal subfields, DG, CA3, and CA1 from individuals with SZ psychosis and controls to elucidate subfield-relevant molecular changes. We also examine changes in gene expression due to antipsychotic medication in the hippocampal subfields from our SZ ON- and OFF-antipsychotic medication cohort. We identify unique subfield-specific molecular profiles in schizophrenia postmortem samples compared with controls, implicating astrocytes in DG, immune mechanisms in CA3, and synaptic scaling in CA1. We show a unique pattern of subfield-specific effects by antipsychotic medication on gene expression levels with scant overlap of genes differentially expressed by SZ disease effect versus medication effect. These hippocampal subfield changes serve to confirm and extend our previous model of SZ and can explain the lack of full efficacy of conventional antipsychotic medication on SZ symptomatology. With future characterization using single-cell studies, the identified distinct molecular profiles of the DG, CA3, and CA1 in SZ psychosis may serve to identify further potential hippocampal-based therapeutic targets.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Perez JM, Berto S, Gleason K, et al. Hippocampal subfield transcriptome analysis in schizophrenia psychosis. Mol Psychiatry. 2020. PMID: 32152472. doi:10.1038/s41380-020-0696-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。